Stocklytics Platform
PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
PILL
$8.95arrow_drop_up3.11%$0.26

Performance History

Chart placeholder
Key Stats
Open$8.70
Prev. Close$8.66
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range8.67
9.05
52 Week Range4.57
10.63
Ratios
P/B Ratio-
Revenue-
Operating M. %-
Earnings-
Earnings Growth %-
EBITDA Margin %-
ROE %-
EPS-

About Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL)

The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is an exchange-traded fund that seeks to provide daily investment results, before fees and expenses, of 300% of the performance of the Dynamic Pharmaceutical Intellidex Index. PILL is designed to take advantage of the potential growth in the pharmaceutical and medical industry. It uses a 3x leverage strategy, which means that it aims to amplify the index's returns on a daily basis. However, it is important to note that this amplification applies only to a single day, and the fund's performance over longer periods can deviate significantly from the index.
The performance of PILL is influenced by various factors, including the performance of the underlying index, market conditions, and the fund's use of leverage. The fund primarily invests in pharmaceutical and medical companies, including both domestic and international securities. This means that the performance of these companies can impact the performance of PILL. Investors should also consider the risks associated with leveraged funds, as they carry a higher level of risk compared to non-leveraged funds.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NYSE

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

add Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF to watchlist

Keep an eye on Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

News

Take Your Investments to a Whole New Level